The role of apolipoprotein E episilon (ε)-4 allele on outcome following traumatic brain injury: A systematic review

Brain Injury

Volumn 29, Issue 9, 2015, Pages 1018-1031

  Lawrence, David W ^a,b,c   Comper, Paul ^b,c,d,e   Hutchison, Michael G ^c,e   Sharma, Bhanu ^c,d,f  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO REHABILITATION INSTITUTE   (Canada)

^e Faculty of Physical Education and Health   (Canada)

^f Department of Cognitive Neurosciences ^*  (Canada)

Author keywords

APOE; Apolipoprotein E; recovery; traumatic brain injury

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; TAU PROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; ATHLETE; BRAIN CONCUSSION; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; DISEASE SEVERITY; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLASGOW OUTCOME SCALE; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; INCIDENCE; INJURY SEVERITY; MEMORY; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; OUTCOME ASSESSMENT; PEDIATRICS; PREVALENCE; PROGNOSTIC ASSESSMENT; PROTEIN FUNCTION; PSYCHOLOGIC TEST; SCORING SYSTEM; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; WECHSLER INTELLIGENCE SCALE; AGED; BRAIN INJURIES; FEMALE; GENETICS; MALE; PROGNOSIS; PSYCHOLOGY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; BRAIN INJURIES; FEMALE; GENOTYPE; HUMANS; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 84939451721     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2015.1005131     Document Type: Article

References (122)

1. Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nature Reviews: Neurology 2013; 9: 231-236
2. Jennett B, Teasdale G, Braakman R, Minderhoud J, Heiden J, Kurze T. Prognosis of patients with severe head injury. Neurosurgery 1979; 4: 283-289
3. Sherer M, Madison CF, Hannay HJ. A review of outcome after moderate and severe closed head injury with an introduction to life care planning. Journal of Head Trauma Rehabilitation 2000; 15: 767-782
4. Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy CW, Penny KI. Disability in young people and adults one year after head injury: Prospective cohort study. British Medical Journal 2000; 320: 1631-1635
5. Ponsford J, Draper K, Schonberger M. Functional outcome 10 years after traumatic brain injury: Its relationship with demographic, injury severity, and cognitive and emotional status. Journal of the International Neuropsychological Society 2008; 14: 233-242
6. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244-248
7. Crawford FC, Vanderploeg RD, Freeman MJ, Singh S, Waisman M, Michaels L, Abdullah L, Warden D, Lipsky R, Salazar A, Mullan MJ. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002; 58: 1115-1118
8. Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochemical Research 2007; 32: 905-915
9. Dardiotis E, Fountas KN, Dardioti M, Xiromerisiou G, Kapsalaki E, Tasiou A, Hadjigeorgiou GM. Genetic association studies in patients with traumatic brain injury. Neurosurgical Focus 2010; 28: E9
10. Jiang Y, Sun X, Xia Y, Tang W, Cao Y, Gu Y. Effect of APOE polymorphisms on early responses to traumatic brain injury. Neuroscience Letters 2006; 408: 155-158
11. Diaz-Arrastia R, Baxter VK. Genetic factors in outcome after traumatic brain injury: What the human genome project can teach us about brain trauma. Journal of Head Trauma Rehabilitation 2006; 21: 361-374
12. Finnoff JT, Jelsing EJ, Smith J. Biomarkers, genetics, and risk factors for concussion. Physical Medicine & Rehabilitation 2011; 3: S452-459
13. Kurowski B, Martin LJ, Wade SL. Genetics and outcomes after traumatic brain injury (TBI): What do we know about pediatric TBI? Journal of Pediatric Rehabilitation Medicine 2012; 5: 217-231
14. Nathoo N, Chetty R, van Dellen JR, Barnett GH. Genetic vulnerability following traumatic brain injury: The role of apolipoprotein E. Molecular Pathology 2003; 56: 132-136
15. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069-1071
16. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-Analysis of APOE4 allele and outcome after traumatic brain injury. Journal of Neurotrauma 2008; 25: 279-290
17. Mahley RW, Nathan BP, Pitas RE. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Annals of the New York Academy of Sciences 1996; 777: 139-145
18. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630
19. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850-852
20. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-Amyloid peptides. Nature Genetics 1996; 14: 55-61
21. Muller W, Meske V, Berlin K, Scharnagl H, Marz W, Ohm TG. Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-Agatoxin IVa-sensitive Ca2+-channel. Brain Pathology 1998; 8: 641-653
22. Tolar M, Keller JN, Chan S, Mattson MP, Marques MA, Crutcher KA. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. Journal of Neuroscience 1999; 19: 7100-7110
23. Pepe MG, Curtiss LK. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. Journal of Immunology 1986; 136: 3716-3723
24. Reyland ME, Williams DL. Suppression of cAMP-mediated signal transduction in mouse adrenocortical cells which express apolipoprotein E. Journal of Biological Chemistry 1991; 266: 21099-21104
25. Veinbergs I, Mante M, Jung MW, Van Uden E, Masliah E. Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1999; 23: 519-531
26. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 1997; 17: 753-758
27. Kerr ME, Kraus M, Marion D, Kamboh I. Evaluation of apolipoprotein E genotypes on cerebral blood flow and metabolism following traumatic brain injury. Advances in Experimental Medicine and Biology 1999; 471: 117-124
28. Lee Y, Aono M, Laskowitz D, Warner DS, Pearlstein RD. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochemistry International 2004; 44: 107-118
29. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA, Cummings JH. Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: A pilot study. British Journal of Nutrition 1998; 79: 133-139
30. Weir CJ, McCarron MO, Muir KW, Dyker AG, Bone I, Lees KR, Nicoll JA. Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 2001; 57: 1097-1100
31. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochimica et Biophysica Acta 1987; 917: 148-161
32. Rall SC Jr., Mahley RW. The role of apolipoprotein E genetic variants in lipoprotein disorders. Journal of Internal Medicine 1992; 231: 653-659
33. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annual Review of Medicine 1996; 47: 387-400
34. Zeng S, Jiang JX, Xu MH, Xu LS, Shen GJ, Zhang AQ, Wang XH. Prognostic value of Apolipoprotein E Epsilon4 Allele in Patients with traumatic brain injury: A meta-Analysis and meta-regression. Genetic Testing & Molecular Biomarkers 2014;18:202-210
35. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 5644-5651
36. Wisniewski T, Frangione B. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters 1992; 135: 235-238
37. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: Binding to soluble Alzheimer's beta-Amyloid. Biochemical and Biophysical Research Communications 1993; 192: 359-365
38. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD. Isoform-specific interactions of apolipoprotein E with microtubule-Associated protein tau: Implications for Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 11183-11186
39. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. Journal of Neuroscience Research 2002; 68: 331-336
40. Alexander S, Kerr ME, Kim Y, Kamboh MI, Beers SR, Conley YP. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. Journal of Neurotrauma 2007; 24: 790-797
41. Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C, Miller JW, Sadrzadeh SM. Haptoglobin phenotype and apolipoprotein E polymorphism: Relationship to posttraumatic seizures and neuropsychological functioning after traumatic brain injury. Epilepsy & Behavior 2009; 16: 501-506
42. Ariza M, Pueyo R, Matarin Mdel M, Junque C, Mataro M, Clemente I, Moral P, Poca MA, Garnacho A, Sahuquillo J. Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry 2006; 77: 1191-1193
43. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Archives of Neurology 2003; 60: 818-822
44. Isoniemi H, Tenovuo O, Portin R, Himanen L, Kairisto V. Outcome of traumatic brain injury after three decades-relationship to ApoE genotype. Journal of Neurotrauma 2006; 23: 1600-1608
45. Jiang L, Yin X, Yin C, Zhou S, Dan W, Sun X. Different quantitative EEG alterations induced by TBI among patients with different APOE genotypes. Neuroscience Letters 2011; 505: 160-164
46. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. Journal of the American Medical Association 1997; 278: 136-140
47. Kerr ME, Ilyas Kamboh M, Yookyung K, Kraus MF, Puccio AM, DeKosky ST, Marion DW. Relationship between apoE4 allele and excitatory amino acid levels after traumatic brain injury. Critical Care Medicine 2003; 31: 2371-2379
48. Kerr ME, Kamboh MI, Kong Y, Alexander S, Yonas H. Apolipoprotein E genotype and CBF in traumatic brain injured patients. Advances in Experimental Medicine and Biology 2006; 578: 291-296
49. Koponen S, Taiminen T, Kairisto V, Portin R, Isoniemi H, Hinkka S, Tenovuo O. APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury. Neurology 2004; 63: 749-750
50. Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery 2000; 47: 651-657; discussion 657-658
51. Leclercq PD, Murray LS, Smith C, Graham DI, Nicoll JA, Gentleman SM. Cerebral amyloid angiopathy in traumatic brain injury: Association with apolipoprotein E genotype. Journal of Neurology, Neurosurgery and Psychiatry 2005; 76: 229-233
52. Liaquat I, Dunn LT, Nicoll JA, Teasdale GM, Norrie JD. Effect of apolipoprotein E genotype on hematoma volume after trauma. Journal of Neurosurgery 2002; 96: 90-96
53. Mauri M, Sinforiani E, Bono G, Cittadella R, Quattrone A, Boller F, Nappi G. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Functional Neurology 2006; 21: 223-228
54. Muller K, Ingebrigtsen T, Wilsgaard T, Wikran G, Fagerheim T, Romner B, Waterloo K. Prediction of time trends in recovery of cognitive function after mild head injury. Neurosurgery 2009; 64: 698-704; discussion 704
55. Olivecrona Z, Koskinen LO. The release of S-100B and NSE in severe traumatic head injury is associated with APOE epsilon4. Acta Neurochirurgica 2012; 154: 675-680; discussion 680
56. Ost M, Nylen K, Csajbok L, Blennow K, Rosengren L, Nellgard B. Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaesthesiologica Scandinavica 2008; 52: 1364-1369
57. Ponsford J, McLaren A, Schonberger M, Burke R, Rudzki D, Olver J, Ponsford M. The association between apolipoprotein E and traumatic brain injury severity and functional outcome in a rehabilitation sample. Journal of Neurotrauma 2011; 28: 1683-1692
58. Smith C, Graham DI, Murray LS, Stewart J, Nicoll JA. Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry 2006; 77: 363-366
59. Sundstrom A, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoven C, Nyberg L. Fatigue before and after mild traumatic brain injury: Pre-post-injury comparisons in relation to Apolipoprotein E. Brain Injury 2007; 21: 1049-1054
60. Sundstrom A, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoven C, Nyberg L. Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele. International Psychogeriatrics 2007; 19: 159-165
61. Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: A prospective cohort study. Brain 2005; 128: 2556-2561
62. Brichtova E, Kozak L. Apolipoprotein E genotype and traumatic brain injury in children-Association with neurological outcome. Child's Nervous System 2008; 24: 349-356
63. Chiang MF, Chang JG, Hu CJ. Association between apolipoprotein E genotype and outcome of traumatic brain injury. Acta Neurochirurgica 2003; 145: 649-653; discussion 653-644
64. Eramudugolla R, Bielak AA, Bunce D, Easteal S, Cherbuin N, Anstey KJ. Long-Term cognitive correlates of traumatic brain injury across adulthood and interactions with APOE genotype, sex, and age cohorts. Journal of the International Neuropsychological Society 2014; 20: 444-454
65. Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000; 54: 1316-1323
66. Lichtman SW, Seliger G, Tycko B, Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 2000; 55: 1536-1539
67. Lo TY, Jones PA, Chambers IR, Beattie TF, Forsyth R, Mendelow AD, Minns RA. Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma. Child's Nervous System 2009; 25: 47-54
68. Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Medicine 1995; 1: 135-137
69. Sundstrom A, Marklund P, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoven C, Nyberg L. APOE influences on neuropsychological function after mild head injury: Within-person comparisons. Neurology 2004; 62: 1963-1966
70. Teasdale G, Jorgensen OS, Ripa C, Nielsen AS, Christensen AL. Apolipoprotein E and subjective sympatmatology following brain injury rehabilitation. Neuropsychological Rehabilitation 2000; 10: 151-166
71. Ashman TA, Cantor JB, Gordon WA, Sacks A, Spielman L, Egan M, Hibbard MR. A comparison of cognitive functioning in older adults with and without traumatic brain injury. Journal of Head Trauma Rehabilitation 2008; 23: 139-148
72. Chamelian L, Reis M, Feinstein A. Six-month recovery from mild to moderate Traumatic Brain Injury: The role of APOE-epsilon4 allele. Brain 2004; 127: 2621-2628
73. Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O. MRI changes and ApoE genotype, a prospective 1-year follow-up of traumatic brain injury: A pilot study. Brain Injury 2007; 21: 1307-1314
74. Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O. Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: A preliminary study. Brain Injury 2009; 23: 396-402
75. Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R. Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology 2006; 67: 756-760
76. Kristman VL, Tator CH, Kreiger N, Richards D, Mainwaring L, Jaglal S, Tomlinson G, Comper P. Does the apolipoprotein ε 4 allele predispose varsity athletes to concussion? A prospective cohort study. Clinical Journal of Sport Medicine 2008; 18: 322-328
77. Liberman JN, Stewart WF, Wesnes K, Troncoso J. Apolipoprotein E epsilon 4 and short-Term recovery from predominantly mild brain injury. Neurology 2002; 58: 1038-1044
78. Mehta KM, Ott A, Kalmijn S, Slooter AJ, van Duijn CM, Hofman A, Breteler MM. Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study. Neurology 1999; 53: 1959-1962
79. Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM. Long term neuropsychological outcome after head injury: Relation to APOE genotype. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 1047-1052
80. Miller MA, Conley Y, Scanlon JM, Ren D, Ilyas Kamboh M, Niyonkuru C, Wagner AK. APOE genetic associations with seizure development after severe traumatic brain injury. Brain Injury 2010; 24: 1468-1477
81. Nathoo N, Chetry R, van Dellen JR, Connolly C, Naidoo R. Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: Influence of ethnic and regional differences. Journal of Neurosurgery 2003; 98: 302-306
82. Olivecrona M, Wildemyr Z, Koskinen LO. The apolipoprotein E epsilon4 allele and outcome in severe traumatic brain injury treated by an intracranial pressure-Targeted therapy. Journal of Neurosurgery 2010; 112: 1113-1119
83. Ponsford J, Rudzki D, Bailey K, Ng KT. Impact of apolipoprotein gene on cognitive impairment and recovery after traumatic brain injury. Neurology 2007; 68: 619-620
84. Pruthi N, Chandramouli BA, Kuttappa TB, Rao SL, Subbakrishna DK, Abraham MP, Mahadevan A, Shankar SK. Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: A study of patient population in India. Neurology India 2010; 58: 264-269
85. Quinn TJ, Smith C, Murray L, Stewart J, Nicoll JA, Graham DI. There is no evidence of an association in children and teenagers between the apolipoprotein E epsilon4 allele and post-Traumatic brain swelling. Neuropathology and Applied Neurobiology 2004; 30: 569-575
86. Rapoport M, Wolf U, Herrmann N, Kiss A, Shammi P, Reis M, Phillips A, Feinstein A. Traumatic brain injury, Apolipoprotein E-ε4, and cognition in older adults: A two-year longitudinal study. Journal of Neuropsychiatry and Clinical Neurosciences 2008; 20: 68-73
87. Stein SC, Graham DI, Chen XH, Dunn L, Smith DH. Apo E genotype not associated with intravascular coagulation in traumatic brain injury. Neuroscience Letters 2005; 387: 28-31
88. Tanriverdi F, Taheri S, Ulutabanca H, Caglayan AO, Ozkul Y, Dundar M, Selcuklu A, Unluhizarci K, Casanueva FF, Kelestimur F. Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: Preliminary data. Journal of Neurotrauma 2008; 25: 1071-1077
89. Terrell TR, Bostick RM, Abramson R, Xie D, Barfield W, Cantu R, Stanek M, Ewing T. APOE, APOE promoter, and Tau genotypes and risk for concussion in college athletes. Clinical Journal of Sport Medicine 2008; 18: 10-17
90. Tierney RT, Mansell JL, Higgins M, McDevitt JK, Toone N, Gaughan JP, Mishra A, Krynetskiy E. Apolipoprotein E genotype and concussion in college athletes. Clinical Journal of Sport Medicine 2010; 20: 464-468
91. Hodgkinson A, Gillett L, Simpson GK. Does Apolipoprotein E play a role in outcome after severe traumatic brain injury? Brain Impairment 2009; 10: 162-168
92. Johnson VE, Murray L, Raghupathi R, Stewart J, Nicoll JA, MacKinnon MA, McIntosh TK, Graham DI. No evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humans. Clinical Neuropathology 2006; 25: 255-264
93. McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013; 136: 43-64
94. Moran LM, Taylor HG, Ganesalingam K, Gastier-Foster JM, Frick J, Bangert B, Dietrich A, Nuss KE, Rusin J, Wright M, Yeates KO. Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury. Journal of Neurotrauma 2009; 26: 1489-1495
95. Neselius S, Zetterberg H, Blennow K, Marcusson J, Brisby H. Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers. PloS One 2013; 8: e81249
96. Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, Phillips C, Gau BA, Welsh-Bohmer KA, Burke JR, et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000; 55: 1158-1166
97. Han SD, Drake AI, Cessante LM, Jak AJ, Houston WS, Delis DC, Filoteo JV, Bondi MW. Apolipoprotein E and traumatic brain injury in a military population: Evidence of a neuropsychological compensatory mechanism? Journal of Neurology, Neurosurgery and Psychiatry 2007; 78: 1103-1108
98. Jellinger KA, Paulus W, Wrocklage C, Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurology 2001; 1: 3
99. Noe E, Ferri J, Colomer C, Moliner B, Chirivella J. APOE genotype and verbal memory recovery during and after emergence from post-Traumatic amnesia. Brain Injury 2010; 24: 886-892
100. Willemse-van Son AH, Ribbers GM, Hop WC, van Duijn CM, Stam HJ. Association between apolipoprotein-epsilon4 and long-Term outcome after traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry 2008; 79: 426-430
101. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-Analyses. European Journal of Epidemiology 2010; 25: 603-605
102. McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee HS, Kubilus CA, Stern RA. Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. Journal of Neuropathology and Experimental Neurology 2009; 68: 709-735
103. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995; 45: 555-557
104. Smith DH, Meaney DF, Shull WH. Diffuse axonal injury in head trauma. Journal of Head Trauma Rehabilitation 2003; 18: 307-316
105. Kulminski AM, Arbeev KG, Culminskaya I, Arbeeva L, Ukraintseva SV, Stallard E, Christensen K, Schupf N, Province MA, Yashin AI. Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan. PLoS Genet 2014; 10: e1004141
106. Han SD, Bondi MW. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 2008; 4: 251-254
107. Zetterberg H, Palmer M, Ricksten A, Poirier J, Palmqvist L, Rymo L, Zafiropoulos A, Arvanitis DA, Spandidos DA, Blennow K. Influence of the apolipoprotein E epsilon4 allele on human embryonic development. Neuroscience Letters 2002; 324: 189-192
108. Becher JC, Keeling JW, McIntosh N, Wyatt B, Bell J. The distribution of apolipoprotein E alleles in Scottish perinatal deaths. Journal of Medical Genetics 2006; 43: 414-418
109. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, Henke K. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex 2007; 17: 1934-1947
110. Ewbank DC. The APOE gene and differences in life expectancy in Europe. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences 2004; 59: 16-20
111. Little DM, Crooks VC, Petitti DB, Chiu V, Schellenberg GD, Slezak JM, Jacobsen SJ. Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States. Journal of the American Geriatrics Society 2009; 57: 231-236
112. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L. APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiology of Aging 2009; 30: 1545-1551
113. Saunders AM, Hulette O, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JC, Rosenberg C. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348: 90-93
114. Collins MW, Grindel SH, Lovell MR, Dede DE, Moser DJ, Phalin BR, Nogle S, Wasik M, Cordry D, Daugherty KM, et al. Relationship between concussion and neuropsychological performance in college football players. Journal of the American Medical Association 1999; 282: 964-970
115. Makdissi M, Darby D, Maruff P, Ugoni A, Brukner P, McCrory PR. Natural history of concussion in sport: Markers of severity and implications for management. American Journal of Sports Medicine 2010; 38: 464-471
116. Lendon CL, Harris JM, Pritchard AL, Nicoll JA, Teasdale GM, Murray G. Genetic variation of the APOE promoter and outcome after head injury. Neurology 2003; 61: 683-685
117. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nature Reviews Genetics 2008; 9: 911-922
118. Harrison PJ, Tunbridge EM. Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008; 33: 3037-3045
119. Dobyns WB, Filauro A, Tomson BN, Chan AS, Ho AW, Ting NT, Oosterwijk JC, Ober C. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. American Journal of Medical Genetics Part A 2004; 129A: 136-143
120. Jasarevic E, Geary DC, Rosenfeld CS. Sexually selected traits: A fundamental framework for studies on behavioral epigenetics. ILAR Journal 2012; 53: 253-269
121. Alonso LC, Rosenfield RL. Oestrogens and puberty. Best Practice & Research: Clinical Endocrinology & Metabolism 2002; 16: 13-30
122. Ortega VE, Meyers DA. Pharmacogenetics: Implications of race and ethnicity on defining genetic profiles for personalized medicine. Journal of Allergy and Clinical Immunology 2014; 133: 16-26